Literature DB >> 10596691

Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs.

A M Bramley1, T Z Vitalis, B R Wiggs, R G Hegele.   

Abstract

Recurrent wheezing and asthma often develop after acute respiratory syncytial virus (RSV) bronchiolitis, but the mechanisms of these sequelae are poorly understood. Using a guinea-pig model of human RSV lung infection, the effects of long-term viral persistence on three hallmarks of asthma: nonspecific airway responsiveness, airway inflammation and airway remodelling were examined. Guinea-pigs were studied 100 days after intranasal instillation of either human RSV or uninfected vehicle, using: 1) acetylcholine challenge to test for airway hyperresponsiveness (AHR); 2) lung histology to quantify the numbers of airway eosinophils and metachromatic cells (mast cells/basophils); 3) airway morphometry of the areas of the airway subepithelial connective tissue, smooth muscle and adventitia, to test for airway remodelling; and 4) immunohistochemistry to identify lung cells containing RSV antigens. The RSV-inoculated group had significantly elevated AHR and airway eosinophils compared to uninfected control animals (p<0.05). There were no significant differences between the two groups in terms of numbers of airway metachromatic cells, or the areas of subepithelial connective tissue, smooth muscle or adventitia. Viral proteins were identified by immunohistochemistry within several types of lung cells. In conclusion, long-term persistence of respiratory syncytial virus in the guinea-pig lung is associated with airway hyperresponsiveness and airway eosinophilia, and these changes may be pertinent to the pathogenesis of postbronchiolitis wheezing and asthma in children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10596691     DOI: 10.1183/09031936.99.14510619

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

Review 1.  Immune responses and disease enhancement during respiratory syncytial virus infection.

Authors:  Peter J M Openshaw; John S Tregoning
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

2.  Viral induction of a chronic asthma phenotype and genetic segregation from the acute response.

Authors:  Michael J Walter; Jeffrey D Morton; Naohiro Kajiwara; Eugene Agapov; Michael J Holtzman
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 3.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

4.  Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.

Authors:  Dora Estripeaut; Juan Pablo Torres; Cynthia S Somers; Claudia Tagliabue; Shama Khokhar; Vijay G Bhoj; Steve M Grube; Aneta Wozniakowski; Ana M Gomez; Octavio Ramilo; Hasan S Jafri; Asuncion Mejias
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

5.  Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment.

Authors:  Yuru Liu; Debra L Haas; Spencer Poore; Sanjin Isakovic; Michelle Gahan; Suresh Mahalingam; Zhen F Fu; Ralph A Tripp
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

Review 6.  Respiratory infections: do we ever recover?

Authors:  John Goulding; Robert Snelgrove; José Saldana; Arnaud Didierlaurent; Mary Cavanagh; Emily Gwyer; Jeremy Wales; Erika L Wissinger; Tracy Hussell
Journal:  Proc Am Thorac Soc       Date:  2007-12

7.  Respiratory syncytial virus persistence in macrophages upregulates Fcgamma receptors expression.

Authors:  Jorge Gaona; Carlos Santiago-Olivares; Enrique Ortega; Beatriz Gómez
Journal:  Viruses       Date:  2014-02-06       Impact factor: 5.048

Review 8.  What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease?

Authors:  Rosa C Gualano; Ross Vlahos; Gary P Anderson
Journal:  Pulm Pharmacol Ther       Date:  2005-04-25       Impact factor: 3.410

Review 9.  Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility?

Authors:  Kristina M James; R Stokes Peebles; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2012-08       Impact factor: 10.793

10.  Host and Viral Factors in Respiratory Syncytial Virus Infection.

Authors:  Peter Mastrangelo; Richard G Hegele
Journal:  Curr Pediatr Rep       Date:  2013-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.